Edesa Biotech Inc buy Brookline Capital Management
Start price
12.10.23
/
50%
€0.39
Target price
12.10.24
€54.12
Performance (%)
0.00%
End price
13.10.24
-
Summary
This prediction is currently being closed. The BUY prediction by Brookline_Capital_Ma is currently unchanged from the start price. Brookline_Capital_Ma has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Edesa Biotech Inc | - | - | - |
| iShares Core DAX® | 3,90 % | 2,67 % | 5,69 % |
| iShares Nasdaq 100 | -2,60 % | -7,93 % | 19,50 % |
| iShares Nikkei 225® | -0,54 % | -9,75 % | 46,05 % |
| iShares S&P 500 | -0,88 % | -1,49 % | 16,91 % |
Comments by Brookline_Capital_Ma for this prediction
In the thread Edesa Biotech Inc diskutieren
Edesa Biotech, Inc. (NASDAQ: EDSA) had its "buy" rating re-affirmed by analysts at Brookline Capital Management. They now have a $57.00 price target on the stock.
Ratings data for EDSA provided by MarketBeat
In the thread Trading Edesa Biotech Inc
Die von Brookline_Capital_Ma gewählte maximale Laufzeit wurde überschritten